drugset / Trial / NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the efficacy and safety of momelotinib in participants with a diagnosis of VEXAS.
Timeline
- Start
- 2026-08-05
- Primary completion
- 2028-12-06
- Completion
- 2031-06-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Momelotinib | Small molecule | — | — |
| Background | Prednisolone | Other / unclassified | — | — |
| Background | Prednisone | Other / unclassified | — | — |